Patients treated for congestive heart failure (CHF) by noncardiologists face a greater risk of not receiving lifesaving prescription therapy for their condition, according to a new study published in the American Journal of Health- System Pharmacy.
The drugs in questionbeta-blockers, angiotensin-converting enzyme inhibitors (ACEIs), and aldosterone antagonistshave all been shown to significantly decrease morbidity and mortality, and are among the medications recommended by the Heart Failure Society of America to treat CHF, hospital pharmacy leaders explained.
But in a study examining prescribing differences by medical specialty, researchers discovered that:
Mr. Rankin is a freelance medical writer.
While many states across our nation are engaged in political battles over the recreational use of marijuana, researchers have been busy studying the medical benefits of cannabidiol.
News from the year's biggest meetings
Clinical features with downloadable PDFs